Default Category
-
Paillasse International SA: Global Market Selection
Marc Fetscherin; Tim PettCase IVEY-9B17A019-EEntrepreneurship, Marketing, StrategyPaillasse International SA was a Swiss-based bread company operating in 15 European markets as of 2016. The company had invented a proprietary, patented process for producing bread concentrate that was used to make high quality, healthy breads. The company was successfully using licensing agreements for the bread concentrate with bakeries throughout the European markets; the latest agreement was with a retailer in Spain. The chief executive offic...Starting at €8.20
-
Malaysia Airlines: The Marketing Challenge after MH370 and MH17
Neeraj Pandey; Gaganpreet SinghCase IVEY-9B15A028-EMarketing, StrategyThe chief executive officer of Malaysia Airlines (MAS) had the daunting task of sustaining a business that had suffered the tragic loss of two of its airliners in a span of just four months. Prior to this, a US$392 million loss, as well as the inability to compete with lower-cost carriers, had posed a great challenge to MAS. Management was planning to initiate a cost-cutting strategy to manage pricing and the competitive challenges of the aviatio...Starting at €8.20
-
The UEFA Academy: Enhancing The Beautiful Game Through Co-Creation
Caroline S.L. TanCase IVEY-9B20A090-EMarketingIn 2020, the head of the Union of European Football Associations (UEFA) Academy, faced some tough decisions surrounding co-creation initiatives. The UEFA Academy was founded in early 2019 to address the learning needs of the football world with the aim ofStarting at €8.20
-
CIBA-GEIGY Pharmaceuticals: Pharma International (Spanish version)
Smith, N. Craig; Quelch, John A.Case HBS-519S11MarketingExamines the decision by Pharma International on whether to launch an antimalarial product in Nigeria and, if so, how that should be implemented. Involves commercial, ethical, and policy considerations. Rich in situation assessment data, the case refers to criticism of pharmaceutical marketing practices in the Third World and CIBA-GEIGY's Servipharm initiative, one response to this problem.Starting at €8.20
-
Nestl : Nutrition, Health, and Wellness
Bell, David E.; McLoughlin, Damien P.; Kindred, NatalieCase HBS-517052-EMarketingStarting at €8.20
-
Nestle
Bell, David E.; Shelman, MaryCase HBS-509001-EMarketingIn April 2008, Paul Bulcke took over as CEO of the world's largest food and beverage company. His predecessor, Peter Brabeck, had delivered 12 years of outstanding results while moving the company toward a new vision of health, nutrition, and wellness. Bulcke's challenge was to swiftly execute the vision and deliver the organic growth and improved margins necessary to meet the "Nestle model."Starting at €8.20
-
Aunt Gotha
Oliver, XavierCase M-1156-EMarketingThe case raises the question of how to expand the population to which a product and its message are addressed.Starting at €8.20
-
Montreaux Chocolate USA: Are Americans Ready for Healthy Dark Chocolate, Teaching Note
Quelch, John A.; Badame, DianeTeaching Note HBS-914502-EMarketingTeaching Note for Product #914501Starting at €0.00
-
Swiss Army: Diversifying into the Fragrance Business
Ilan Alon; Marc Fetscherin; Claudia CarvajalCase IVEY-9B14A066-EEntrepreneurship, Marketing, StrategyIn 2005, Victorinox, the original producer of the Swiss Army Knife, acquired Wenger, including the fragrance label “Swiss Army Fragrance.” The acquisition of Wenger allowed Victorinox to become the only producer of the famous Swiss Army Knife as well as the key player in Swiss Army watches. Victorinox’s head of marketing was asked to design a business strategy that would successfully allow the company to enter the fragrance industry. How should V...Starting at €8.20
-
Vibrance Kegel Device: Capturing Mindshare
Doreen KumCase IVEY-9B16A021-EEntrepreneurship, Marketing, StrategyThe Vibrance Kegel Device (VKD) was an intra-vaginal device that helped women correctly identify and strengthen their pelvic floor muscles to prevent and improve health issues related to urinary incontinence, back pain, and sexual dysfunction. The VKD was owned and marketed by Bioinfinity, a three-person, start-up company based in Malaysia. Despite being an innovative and award-winning product, its marketing strategy was challenging as its target...Starting at €8.20